By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Institute of Allergy And Infectious Diseases (NIAID) 

31 Center Drive MSC 2520
Building 31, Room 7A-50
Bethesda  Maryland  20892-2520  U.S.A.
Phone: 301-496-5717 Fax:


SEARCH JOBS


Industry
Healthcare


Collaborations

MedImmune, LLC 

MedImmune 





Company News
Potent HIV Antibody Research Has Opened Up Possibilities For HIV Prevention, Treatment, National Institute of Allergy And Infectious Diseases (NIAID) And Columbia University Study 3/4/2014 6:39:29 AM
Vitamin A Deficiency Promotes Type 2 Barrier Immunity, National Institute of Allergy And Infectious Diseases (NIAID) Reveals 1/24/2014 6:47:43 AM
Vivaldi Biosciences Inc. Signs Cooperative Research And Development Agreement (CRADA) With National Institute of Allergy And Infectious Diseases (NIAID) To Develop Live Attenuated Influenza Vaccine Against Influenza H7N9 1/21/2014 9:23:08 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Marburg Virus Disease 12/30/2013 8:30:42 AM
National Institute of Allergy And Infectious Diseases (NIAID) And National Institutes of Health (NIH) Researchers Identify Resistant Genetic Marker To Key Malaria Drug 12/20/2013 7:46:38 AM
New Medical Device Extremely Effective at Preventing HIV in Women, National Institute of Allergy And Infectious Diseases (NIAID) Study 9/30/2013 6:17:28 AM
Soligenix (SNGX.OB) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued up to $6.4 Million for the Development of OrbeShield™ in GI ARS 9/25/2013 10:07:20 AM
Biocryst Pharmaceuticals (BCRX) Awarded Contract by the National Institute of Allergy And Infectious Diseases (NIAID) to Develop BCX4430 for the Treatment of Marburg Virus Disease 9/17/2013 10:53:05 AM
New Tests to Detect Drug-Resistant Malaria, National Institute of Allergy And Infectious Diseases (NIAID) Study 9/11/2013 7:00:15 AM
Enanta Pharmaceuticals, Inc. Announces National Institute of Allergy And Infectious Diseases (NIAID) Will Fund Further Development of a Novel Bicyclolide 9/3/2013 10:06:53 AM
12345678910...
//-->